Back

Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants

28 August 2026 (16:30 - 16:45)
Organised by: Logo
Congress Presentation Part of: Nature Medicine: 2026 highlights e-Cardiology/Digital Health ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Shinwan Kany

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)

3 More presentations in this session

Presentation thumbnail
Remote monitoring of heart failure exacerbations using a smartwatch
Doctor C. McIntosh (Toronto, CA)
Slides Video
Presentation thumbnail
Low plastic diet and urinary levels of plastic-associated phthalates and bisphenols: the randomised controlled PERTH Trial
Professor M. Lucas (Perth, AU)
Slides Video
Presentation thumbnail
Multinational validation of cardiovascular risk equations: analysis of over 6.4 million individuals from cohorts and randomised trials
Associate Professor R. Major (Leicester, GB)
Slides Video

Access the full session

Session thumbnail
Nature Medicine: 2026 highlights
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 16:30 CET
You may be interested in
thumbnail
Congress Session
Aetiology, comorbidities, and outcomes in heart failure
28 August 2026
thumbnail
Congress Presentation
Clinical efficacy of sotagliflozin for heart failure outcomes across cardiac biomarker levels in SCORED
10 May 2026
thumbnail
Congress Presentation
Exome sequencing in over 63,000 patients in TIMI trials uncovers pathogenic cardiomyopathy variant carriers with high risk for heart failure and cardiovascular death
2 September 2024
thumbnail
Congress Session
Further Insights into SGLT2i treatment for heart failure
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources